Aidapak Recalls Phenytoin Sodium ER Capsules Due to Labeling Error
Aidapak Services is recalling Phenytoin Sodium ER capsules because they may have been mislabeled as Lithium Carbonate ER tablets.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (mislabeling) without reported injuries or illnesses, fitting the criteria for moderate severity.
Plain-English summary
Aidapak Services, LLC is recalling Phenytoin Sodium ER, Capsule, 30 mg (NDC 00071374066) due to a labeling error. The recalled product may have been mislabeled as Lithium Carbonate ER, Tablet, 450 mg (NDC 00054002025).
The affected product has pedigree W003331 and an expiration date of 6/19/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers and healthcare providers should check their inventory for this specific product and stop using it if the labeling is incorrect. They should contact their pharmacist or the recalling firm for further instructions on how to return or dispose of the product.
The recalled product
- Product
- PHENYTOIN SODIUM ER, Capsule, 30 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00071374066.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- PHENYTOIN SODIUM ER
- Capsule
- 30 mg has the following codes: Pedigree: W003331
- EXP: 6/19/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- ModerateGore Viabil Short Wire Biliary Endoprosthesis Recalled for Incorrect Length Labeling
FDA (Devices) · 2026-10-21
- ModerateIn2bones Recalls Partially Threaded Bone Screws Due to Labeling Error
FDA (Devices) · 2026-10-21
- SevereInstrumentation Laboratory Recalls HemoslL AcuStar HIT-lgG In Vitro Diagnostic Reagents
FDA (Devices) · 2026-10-21
- SevereDeano's Pasta Recalls Pear and Pecorino Ravioli for Undeclared Lobster
FDA (Food) · 2026-10-21
Similar recalls
- ModerateFDA Recalls Zinc Sulfate Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Propranolol Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22
- SevereCalcium Citrate Tablets Recalled for Potential Lithium Carbonate Labeling Error
FDA (Drugs) · 2014-01-22
- ModerateFosinopril Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Nitrofurantoin Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- SevereAidapak Recalls Docusate Sodium Capsules Due to Labeling Mixup
FDA (Drugs) · 2014-01-22